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Abstract
Renilla luciferase (RLUC) is a popular reporter enzyme for gene expression and biosensor
applications, but it is an unstable enzyme whose catalytic mechanism remains to be elucidated. We
titrated that one RLUC molecule can turn over about one hundred molecules of coelenterazine
substrate. Mutagenesis of active site residue Pro220 extended the half-life of photon emission,
yielding brighter luminescence in E. coli. Random mutagenesis uncovered two new mutations that
stabilized and increased photon emission in vivo and in vitro, while ameliorating substrate inhibition.
Further amended with a previously identified mutation, a new triple mutant showed a threefold
improved kcat, as well as elevated luminescence in Arabidopsis. This advances the utility of RLUC
as a reporter protein, biosensor, or resonance energy donor.

Background
Renilla luciferase (RLUC) is a cofactor-less, single subunit,
blue light emitting luciferase isolated from the marine
anthozoan Renilla reniformis (RLUC, E.C. number
1.13.12.5, luciferin-2-monooxygenase, decarboxylating)
[1]. Aside from its utility as a reporter for gene expression
assays, RLUC has also found application in assays for protein interaction based on fragment complementation [2]
and bioluminescence resonance energy transfer [3]. The
substrate of Renilla luciferase, coelenterazine, consists of
a central aromatic imidazopyrazinone, which is derivatized with p-hydroxy-phenyl (R1), benzyl (R2), and phydroxy-benzyl (R3) moieties. Using molecular oxygen,
RLUC catalyzes an oxidative decarboxylation in which the
imidazole ring is opened and carbon dioxide is released
[4-7]. Relaxation of the electronically excited coelenteramide reaction product is accompanied by emission of a
photon of blue (~470 nm) light.

Compared to the calcium-stimulated photoprotein, aequorin, and its relatives, which utilize the same substrate as
RLUC, the catalytic mechanism of RLUC is not yet well
understood [8,9]. Photoproteins are single turnover
enzymes. Removal of the coelenteramide product and
binding of a fresh substrate molecule require a reducing
agent and the concomitant removal of calcium [10].
RLUC is not homologous to aequorin but evolved from
an α/β hydrolase ancestor closely related to current bacterial dehalogenases. Its structure has recently been solved
[11]. Within the large hydrophobic active site, the putative catalytic triad consists of Asp120, His285, and
Glu144. Mutagenesis data and inactivation with diethylpyrocarbamate indicate that His285 is important for catalysis, presumably as a general base [12,13]. A model for
how coelenterazine and its peroxidized reaction intermediate might be positioned in the active site has been proposed [13].
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Re-engineering of the RLUC sequence might ameliorate
undesirable properties that arise upon expression in heterologous hosts, which lack RLUCs two partner proteins,
a green fluorescent protein and a calcium-responsive coelenterazine binding protein [14,15]. Previous consensusguided mutagenesis has already led to RLUC versions with
improved stability in serum, improved ability to utilize
the purple-emitting substrate, bisdeoxycoelenterazine,
and altered spectral properties [12,16]. RLUC is well
known to be inactivated in the presence of substrate,
resulting in most of the light to be emitted as a flash of a
few seconds in length. While a short half-life of the
enzyme might be beneficial for time-resolved gene expression studies, it is undesirable for protein-interaction studies based on bioluminescence resonance energy transfer
[5,17,18].
Here, we describe the results of site directed and random
mutagenesis in conjunction with expression and purification of recombinant RLUC enzyme in E. coli with the goal
of improving specific enzymatic parameters of RLUC. We
describe novel mutants with increased kcat, extended halflife of photon emission in vitro and in vivo, and enhanced
light emission upon expression in plant cells.

Methods
Mutagenesis and other recombinant DNA techniques
The wild type Renilla reniformis luciferase cDNA obtained
from plasmid pBS-35S-RLUC-attR (Genbank accession,
AY995136) [17] was subcloned into the expression vector
pET30(a) as an NcoI-BamHI fragment, thus adding an Nterminal histidine tag and linker sequence (His-RLUC)
[13]. For random mutagenesis, the RLUC cDNA was
amplified using an error-prone PCR procedure, GeneMorpho®II Random Mutagenesis (Stratagene, La Jolla, CA). A
library of 1300 putative mutant clones (strain
BL21(DE3)) was grown in LB in white 96-well microtiter
plates (Packard, Meriden, CT) to an optical density of
about 0.6. Colonies were surveyed for RLUC activity in the
presence of 2 μM native coelenterazine (Biotium, Hayward, CA) in the PolarStar plate reader (BMG Labtech,
Durham, NC). Candidates with elevated RLUC activity
were reconfirmed by inducing RLUC expression at OD =
0.5 with 1 mM IPTG for 1 hour at 30°C and the mutation
was identified by DNA sequencing. Subsequently, mutations were also introduced into a human codon-optimized RLUC cDNA (hRLUC, Genbank accession,
AAK53368, Packard, Meriden, CT). Site directed mutagenesis was performed using the Quickchange procedure
(Stratagene, La Jolla, CA). Mutations were confirmed by
resequencing of the entire RLUC coding region to guard
against unintended secondary mutations. To generate
recombination cloning vectors, the appropriate fragments
of pBS-35S-hRLUC-attR (Genbank accession AY995138)
and
pBS-35S-attR-hRLUC
(Genbank
accession
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AY995140) [17] were replaced with the corresponding
NheI/BglII restriction fragment from pET30(a)-SuperhRLUC that contained the M185V, K189V, and V267I mutations. The entire SuperhRLUC coding regions of the
recombination vectors were confirmed by sequencing.
Expression and purification of RLUC
RLUC expression in E. coli strain BL21(DE3)pLysS was
induced with 1 mM IPTG for 3 h hours at 30°C. The accumulation of RLUC in E. coli was routinely checked by cell
lysis and gel electrophoresis and Coomassie Blue-staining. Mutant proteins generally accumulated to similar levels. RLUC was purified from the soluble cytosolic fraction
over a nickel column (His-Bind Kit, Novagen, Darmstadt,
Germany) following standard procedures that included
sonication, centrifugation of cell debris at 12,000 rpm for
10 minutes at 4°C, and filtration of the supernatant
through a 0.45 micron filter to prevent clogging of resin.
Protein was affinity purified according to the manufacturer's protocol and eluted with 1 M imidazole, 0.5 M
NaCl, 20 mM Tris-HCl, pH, 7.9. After elution, RLUC was
dialyzed overnight against 2 L of phosphate buffered
saline (PBS, pH7.2) in order to remove imidazole. Protein
concentration was determined using the BCA assay
(Pierce, Rockford, IL) with BSA as a standard. Alternatively, the protein concentration of preparations that were
free of imidazole was measured by UV-absorbance using
an extinction coefficient of 65,040 M-1 cm-1 [19]. Purified
RLUC protein was stored in PBS with 50% glycerol at 70°C in small aliquots or stored at 4°C for up to 2 weeks.
Kinetics of RLUC enzyme activity
Enzyme assays were conducted using freshly purified
RLUC enzyme at a concentration of 1 nM or as otherwise
indicated in 1 ml PBS (pH 7.2). Native coelenterazine
substrate was added from a 250× stock solution of the
indicated concentration in ethanol (final ethanol concentration, 0.8%), the solution was mixed by tapping to
ensure a maximal supply of oxygen, and the luminescence
activity was recorded in the TD20/20 luminometer (Turnerdesigns, Sunnyvale, CA). The first 5-second luminescence reading was taken as a measure of enzyme activity.
The KM values of wild type RLUC and selected mutants
were calculated according to standard Michaelis-Menten
theory using Prism software (GraphPad Software Inc., San
Diego, CA) from at least 3 repeat measurements. Several
independent protein preparations yielded similar KM values.
Emission spectra
Luminescence spectra were recorded under the same condition as the enzyme assay using a spectroluminometer
(Photon Technology International, Inc., Birmingham,
NJ), except that the assay volume was 2 ml. Native coelenterazine substrate was 2 μM (ethanol concentration,
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0.8%). Protein concentration was 10 nM purified enzyme
or as otherwise indicated. Generally, the emission spectrum was analyzed with the Felix32 software (Photon
Technology International, Inc., Birmingham, NJ). All
spectra were recorded at 1 nm per second from short to
long wavelength. No adjustments for detector sensitivity
or luminescence decay over time were made; nevertheless,
the spectra are directly comparable among each other and
emphasize the differences in emission in the short-wavelength region.
Substrate/enzyme titration
The amount of RLUC enzyme needed to deplete a nearly
saturating amount of substrate (0.1 ml of 1 μM or 10 μM
coelenterazine) was determined by titration. Parallel reactions were set up with RLUC at concentrations between
100 nM and 1 nM in 100 μl of assay buffer (50 mM potassium phosphate, pH 7.4, 500 mM NaCl, 1 mM EDTA) [5].
Reactions were allowed to proceed for at least 2 hours
until luminescence had decayed to near-background levels. Each spent reaction was then split into two aliquots.
To one aliquot fresh enzyme (10 nM) was added. If no
increase in luminescence was observed it was concluded
that the substrate must have been used up completely
allowing us to deduce the stoichiometry between enzyme
and substrate. The second 50 μl aliquot was supplemented with 10 μM substrate to check whether the substrate had been used up completely by the enzyme or
whether RLUC activity had been depleted.
Spectrophotometric assay of RLUC activity
The spectrum of a 10 μM solution of coelenterazine in
assay buffer was recorded. RLUC was added to 100 nM
and the spectrum re-recorded after 10 minutes and 60
minutes of reaction time. The extent of spontaneous degradation of coelenterazine was determined in a control
reaction without added enzyme.
Plant growth condition and transgenic lines
Columbia wild type and transgenic seedlings were germinated on 0.8% agar medium containing Murashige and
Skoog salts (MS; Sigma, St. Louis) and 1% sucrose without
antibiotics. The transgenic plants expressing the hRLUC or
SuperhRLUC cassettes were grown on a MS selection
media containing 1.5 mg/l ammonium glufosinate herbicide (Basta; Sigma, St. Louis).
Measurement of Renilla luciferase activity in transgenic
Arabidopsis
Luminescence units were measured from 10 day-old seedlings in the presence of 2 μM coelenterazine (Biotium,
Hayward, CA) in water using a TD-20/20 tube luminometer that is equipped with the blue-color filter. After adding 2 μM coelenterazine, samples were incubated in
darkness for 10 min at room temperature to allow the
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substrate to penetrate into plants and to allow delayed
chlorophyll autofluorescence to decay [17].
Protein extraction from plants and western blotting
Plant protein was extracted with passive lysis buffer from
the Dual-Luciferase® Reporter Assay System (Promega,
Madison, WI) and RLUC detected by western blotting
using a monoclonal antibody (Chemicon, Temecula, CA).
Photon-counting images
Transgenic 7–10 days old Arabidopsis seedlings were
imaged on a Nikon microscope with a Hamamatsu C2400
ICCD (Meyer Instruments, Houston, TX). Seedlings were
pre-incubated in 2 μM coelenterazine for 5 min and then
photon emission was recorded for 5 min. Images were
pseudo-colored with ImageJ (NIH, Bethesda, MD).

Results and discussion
Previous docking simulations and mutagenesis of RLUC
active site residues D120, E144, and H285, which are conserved with the catalytic triad of the dehalogenase LinB,
suggested that they also underlie the catalytic mechanism
of RLUC. Meanwhile, two other residues, N53 and W121,
were proposed to function in binding to the R1 ring of
coelenterazine [13]. When the neighboring P220 was
mutated to ten different residues, several mutants displayed the unusual characteristic that E. coli in vivo luminescence was initially low, but rose dramatically over
time, soon surpassing the peak luminescence of cells
expressing wild-type RLUC (Figure 1A) [13]. When tested
in vitro after purification, the P220G and P220L mutant
proteins showed only 4% and 16% of the initial luciferase
activity of wild-type RLUC, respectively (not shown).
However, compared to wild-type RLUC and many other
mutants tested, whose half-life of photon emission in vitro
was about 40 seconds, P220G and P220L yielded a strikingly more stable luminescence output over time (Figure
1B).
It is unclear why RLUC rapidly loses its enzymatic activity
when in contact with substrate. The turnover number of
RLUC is low (111 μmol min-1 μmol-1 enzyme) [5] but the
sum total of substrate molecules turned over by one molecule of RLUC has not been reported. The loss of luminescence activity cannot be attributed to oxygen depletion
because the concentration of dissolved oxygen in water
(280 μM at 20°C) is much higher than that needed to
react with coelenterazine (1 μM). By titrating the amount
of wild-type enzyme needed to deplete the luminescence
potential of a solution of coelenterazine substrate, we
determined that one molecule of enzyme is able to turn
over up to 100 molecules of native coelenterazine (Figure
2A). To confirm that a sufficient amount of RLUC causes
complete turnover of the substrate, the enzymatic reaction
was also followed by measuring absorbance of coelenter-
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Figure 1of RLUC enzyme activity
Half-life
Half-life of RLUC enzyme activity. (A) Time course of in vivo luminescence in E. coli cells expressing wild type RLUC and
two P220 mutants. (B) Time course of in vitro luminescence of wild type RLUC and two P220 mutants. Enzyme and substrate
concentrations were 10 nM and 2 μM respectively in PBS buffer pH7.2. Absolute activities were normalized for better comparison (first time-point = 100). Results shown are averages from three biological replicates each performed in triplicate. The
Coomassie stained SDS-PAGE gels below show that the P220 mutants and wild-type RLUC accumulate to equivalent levels in
E. coli. RLU stands for relative luminescence units.

azine at 420 nm (Figure 2B). The vast majority of photons
are emitted within the first ten minutes of the reaction
(Figure 1B), which coincides with the drop in coelenterazine absorbance at 420 nm and appearance of a new peak
at 350 nm, which is attributed to coelenteramide. Therefore, the drop in luminescence cannot simply be

explained by a drop in quantum efficiency. Coelenteramide is a strong competitive inhibitor of RLUC (KI ~ 23
nM) [6], and its accumulation must contribute to the loss
of activity. However, it cannot be solely responsible,
because enzyme activity is also lost at enzyme concentrations as low as 1 pM, when, in light of the titration data,
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2
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Decay properties of RLUC enzyme activity. (A) A titration assay indicates that 1 molecule of RLUC can turn over ~100
molecules of coelenterazine. A 1 μM solution of native coelenterazine substrate was incubated with increasing amounts of
RLUC enzyme (1 nM to 100 nM) and the reaction was allowed to go to completion. Once light emission had ceased, the reaction was split in half and supplemented with fresh enzyme (squares) to examine whether all substrate had been depleted; or
with fresh substrate (circles) to check for residual enzyme activity. Note, if an excess of substrate was added, the loss of RLUC
activity was not reversible by adding fresh substrate. (B) Spectrophotometric confirmation of substrate turnover by RLUC.
Absorbance spectra were recorded for 10 μM coelenterazine before (black trace) and after (blue trace) turnover by 100 nM
RLUC. Two traces of partially completed reactions are shown for comparison (red and green traces). (C) Half life of RLUC
activity in the in vitro assay as measured by luminescence decay kinetics.
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the concentration of accumulated coelenteramide is far
below the KI (Figure 2C).
Next, we screened RLUC mutants generated by random
mutagenesis for mutants with increased peak of light
emission in E. coli or increased stability of light emission
over time. Upon DNA sequencing and protein purification, the activities of two mutants, V267I and K189V, were
elevated over wild-type RLUC (Table 1). A third mutant,
M185G, was of interest because of a slightly increased half
life (not shown), although kcatwas decreased. While K189
and M185 lie in the presumptive gateway that guides the
substrate into the active site [11], V267 lies outside of the
active site, as do most of the eight mutations constituting
the RLUC8 mutant, which has an increased kcat [12].
The coelenteramide reaction product relaxes from the
excited state to the ground state under emission of a photon of light. The precise peak wavelength of light emission
is influenced by the protonation state of the reaction
product and is also dependent on the physical environment (hydrophobicity) in the active site [20]. The emission spectra of K189V and M185G were similar to wildtype RLUC (not shown). In contrast, V267I showed two
major peaks, a blue-shifted shoulder of 390 nm, indicative of the formation of a neutral coelenteramide [7,2123] and a blue-shifted maximum at 450 nm [see Additional file 1].
The putative beneficial mutations, K189V and V267I,
were combined into a double mutant, named RLUC+. The
two mutations appeared to act additively, yielding a more
Table 1: Activities of RLUC mutants selected for improved
enzymatic activity.

Mutations

Name

Activity ± SD

Condition

His-RLUC
RLUC+
SuperRLUC

100
163 ± 33
128 ± 16
317 ± 82
411 ± 113

in vitro 1)
in vitro
in vitro
in vitro
in vitro

100
175 ± 70
425 ± 120
475 ± 130

in vivo 2)
in vivo
in vivo
in vivo

Native RLUC cDNA
none
V267I
K189V
K189V+V267I
M185V+K189V+V267I

Codon-optimized RLUC cDNA (hRLUC)
none
K189V
M185V+K189V
M185V+K189V+V267I
1) In

His-hRLUC
SuperhRLUC

vitro activites are initial luminescence values upon addition of
substrate (2 μM coelenterazine). The unmutated version was set to
100.
2) In vivo activities are luminescence activities from E. coli strain BL21
without IPTG induction (2 μM coelenterazine).

than two-fold increase in the apparent kcat of light emission compared to wild-type RLUC (Figure 3A). From
another set of RLUC mutations that yielded increased
luminescence in mammalian cells [12,24], we selected
M185V, a mutation that increased the stability of enzyme
activity in serum and the ability to luminesce using the
substrate bis-deoxycoelenterazine [12]. Its incorporation
into RLUC+ yielded a slight further increase in light emission (SuperRLUC; Figure 3A). Including the P220G mutation provided no further enhancement (not shown).
Neither RLUC+ nor SuperRLUC had an altered KM and
their emission spectra were similar to wild type (Figure 3A
and 3B). Interestingly, the K189V mutation suppressed
the blue shift and the marked purple emission detected in
the V267I mutant. However, the luminescence of SuperRLUC had a two-fold longer half-life in vitro compared to
wild-type RLUC (Figure 3C). RLUC is known to be inhibited by aggregation at high concentrations of substrate
(above 3 μM) [6]. RLUC+ and SuperRLUC were less sensitive to substrate inhibition (Figure 3D). Elevated RLUC
activity was also observed when the mutations were introduced into a codon-optimized cDNA (hRLUC, Table 1).
SuperhRLUC gave rise to approximately two-fold higher
luminescence values than regular hRLUC when expressed
in stably transgenic Arabidopsis seedlings (Figure 4A and
4B). In addition, SuperhRLUC protein extracted from
plants had a prolonged half life of photon emission [see
Additional file 2]. For easy construction of SuperhRLUC
fusion proteins, new recombination cloning vectors harboring SuperhRLUC were generated (Figure 4C); these are
available from the corresponding author upon request.
The improved luciferase activity and stability of SuperhRLUC in Arabidopsis should be beneficial for utilization of
RLUC as a reporter protein or biosensor. Why RLUC suffers from irreversible inactivation of its enzymatic activity
still requires further study. Dramatic improvements in
luminescence emission can be expected if this limitation
can be resolved.

Conclusion
Mutant versions of Renilla luciferase with increased kcat
were identified from a library of random mutations
expressed in E. coli. A combination of two or three mutations resulted in increased activity of the Renilla luciferase
reporter enzyme in transgenic Arabidopsis.

Abbreviations
RLU: relative light units; RLUC: Renilla luciferase.
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Enzyme
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Figure 4 (see of
Improvement
previous
light emission
page) by SuperhRLUC in Arabidopsis and recombination vectors
Improvement of light emission by SuperhRLUC in Arabidopsis and recombination vectors. (A) In vivo luminescence measurement of transgenic Arabidopsis expressing regular RLUC (2 lines), hRLUC, or SuperhRLUC. Asterisk represents
the significant increase of luciferase activity of SuperhRLUC over hRLUC (P < 0.01, two tailed t-test; n = 4 repeats with 25
seedlings each). The immunoblot below probed with RLUC antibody confirms that hRLUC and SuperhRLUC (36 kDa) accumulate to similar, high, levels; the original RLUC can only be detected on the immunoblot after prolonged development. The
arrowhead indicates a non-specific immunoreaction. (B) Photon-counting images of representative seedling roots. Photon
emission in the primary roots of SuperhRLUC transgenic Arabidopsis was stronger compared to regular hRLUC (lower panels). The upper panels show a 3-dimensional version of the images below in which photon intensity is encoded in the third axis.
Seedlings were incubated in 2 μM coelenterazine and imaged for 5 min. (C) pBS-SuperhRLUC-attR and pBS-attR-SuperhRLUC
are recombination vectors for expression of SuperhRLUC fusion proteins, which contain the lambda att recombination sites
utilized by the Gateway™ (Invitrogen) system [25]. Sequence elements flanking an insert (target cDNA) are shown before
(pENTR) and after (Destination) attL × attR recombination. The 35S indicates a strong promoter in plants, which can be
replaced by restriction digestion with KpnI and SwaI or AvrII. The ccdB gene provides for counter-selection of non-recombinants.
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